LCTX
AMEX · Biotechnology
Lineage Cell Therapeutics In
$1.45
-0.10 (-6.45%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,687.6% upside
Low Target
$29.91
Average Target
$40.42
High Target
$53.83
Current Price
$1.45
Current
$1.45
$1.45
Target
$40.42
$40.42
$29.91
$40.42 avg
$53.83
Scenario Analysis
Bear Case
$29.91
1,962.8%
Low target
Base Case
$40.42
+2,687.6%
Avg target
Bull Case
$53.83
+3,612.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.09
-30.6% from high
52-Week Low
$0.37
+297.2% from low
Target vs 52W High
$40.42
+1,834.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |